Abstract
In December 2019, a novel respiratory coronavirus named SARS-CoV-2 appeared in China, causing the disease termed COVID-19 that has caused millions of infections worldwide. In this article, we have analyzed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. From our analysis, it becomes clear that there is a big difference in the immune response against SARS in children, young adults and the elderly, both at the innate and adaptive levels. Taking this information into account, we have studied the strategies that are being used for the development of COVID-19 vaccines. We discussed the perspectives for obtention and worldwide distribution of reliable vaccines using this perspective. The conclusion is that different vaccines may be protective for different age segments within the population, depending on the strategy used for their design. Therefore, it will become necessary for several vaccines to reach the finish line, not only to ensure availability, but also to guarantee an adequate immune response at the individual level.
Keywords: COVID-19, SARS-CoV-2, infection, coronavirus immune response, vaccine development, vaccine phases.
Current Medicinal Chemistry
Title:COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed
Volume: 28 Issue: 20
Author(s): Mercedes Jimenez*, Nuria E. Campillo*Matilde Canelles
Affiliation:
- Centro de Investigaciones Biologicas Margarita Salas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid,Spain
- Centro de Investigaciones Biologicas Margarita Salas (CIB-CSIC), Ramiro de Maeztu 9, 28040 Madrid,Spain
Keywords: COVID-19, SARS-CoV-2, infection, coronavirus immune response, vaccine development, vaccine phases.
Abstract: In December 2019, a novel respiratory coronavirus named SARS-CoV-2 appeared in China, causing the disease termed COVID-19 that has caused millions of infections worldwide. In this article, we have analyzed existing evidence on the immune response against SARS coronaviruses in order to understand the possible outcome of a vaccine for COVID-19. From our analysis, it becomes clear that there is a big difference in the immune response against SARS in children, young adults and the elderly, both at the innate and adaptive levels. Taking this information into account, we have studied the strategies that are being used for the development of COVID-19 vaccines. We discussed the perspectives for obtention and worldwide distribution of reliable vaccines using this perspective. The conclusion is that different vaccines may be protective for different age segments within the population, depending on the strategy used for their design. Therefore, it will become necessary for several vaccines to reach the finish line, not only to ensure availability, but also to guarantee an adequate immune response at the individual level.
Export Options
About this article
Cite this article as:
Jimenez Mercedes *, Campillo E. Nuria *, Canelles Matilde , COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed, Current Medicinal Chemistry 2021; 28 (20) . https://dx.doi.org/10.2174/0929867327666201027153123
DOI https://dx.doi.org/10.2174/0929867327666201027153123 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cross-Talk between Oxidative Stress and Pro-Inflammatory Cytokines in Acute Pancreatitis: A Key Role for Protein Phosphatases
Current Pharmaceutical Design Contribution of Latin American Countries to Cancer Research and Patent Generation: Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Novel Computational Approaches in QSAR and Molecular Design Based on GA, Multi-Way PLS and NN
Current Computer-Aided Drug Design The Treatment of Painful Diabetic Neuropathy
Current Diabetes Reviews Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative Diseases
Current Medicinal Chemistry Medicinal Chemistry of Indolylglyoxylamide GABAA/BzR High Affinity Ligands: Identification of Novel Anxiolytic/Non Sedative Agents
Current Topics in Medicinal Chemistry Preface
Current Topics in Medicinal Chemistry An Overview of Recent Development in Visible Light-mediated Organic Synthesis over Heterogeneous Photo-nanocatalysts
Current Organic Synthesis Gene Therapy in In Vivo Isolated Perfusion Models
Current Gene Therapy Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design Evaluation of Substituted Benzaldehydes Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy The Antagonists of Endothelin Receptors: Results and Perspectives
Current Pharmaceutical Analysis Chemotherapy In Japanese Encephalitis: Are We There Yet?
Infectious Disorders - Drug Targets Investigation of Potential Inhibitors of Chorismate-Utilizing Enzymes
Current Medicinal Chemistry Preface
Current Molecular Pharmacology A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case
Infectious Disorders - Drug Targets Ivermectin in COVID-19 Management: What is the Current Evidence?
Infectious Disorders - Drug Targets Deep Learning Based COVID-19 Detection Using Medical Images: Is Insufficient Data Handled Well?
Current Medical Imaging The Emergence of Omicron SARS-CoV-2 Variant (B.1.1.529): The Latest Episode in the COVID-19 Pandemic with a Global Riposte
Infectious Disorders - Drug Targets